Epilepsy and neurodevelopmental disorders of language

Current Opinion in Neurology

Volumn 24, Issue 2, 2011, Pages 126-131

  Pal, Deb K ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

comorbidity; connectivity; copy number variant; dyspraxia; pleiotropy; speech

Indexed keywords

CARBAMAZEPINE; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; PEPTIDES AND PROTEINS; SRPX2 PROTEIN; SULTIAME; TRANSCRIPTION FACTOR FOXP2; UNCLASSIFIED DRUG;

ANTICONVULSANT THERAPY; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHROMOSOME 14Q; CHROMOSOME DELETION; COGNITIVE DEFECT; COMORBIDITY; COPY NUMBER VARIATION; DEVELOPMENTAL DISORDER; DYSPRAXIA; ELECTROENCEPHALOGRAPHY; EPILEPSY; GENETIC ANALYSIS; HAPPY PUPPET SYNDROME; HUMAN; INTELLIGENCE QUOTIENT; LANGUAGE DISABILITY; MICROCEPHALY; NEUROIMAGING; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PHENOTYPE; ROLANDIC EPILEPSY; SPECIFIC LANGUAGE IMPAIRMENT; SPEECH DISORDER; SPEECH SOUND DISORDER;

COMORBIDITY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; LANGUAGE; LANGUAGE DISORDERS; MAGNETIC RESONANCE IMAGING; NERVE TISSUE PROTEINS; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS;

EID: 79953059357     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e328344634a     Document Type: Article

References (38)

1. Law J, Boyle J, Harris F, et al. Prevalence and natural history of primary speech and language delay: findings from a systematic review of the literature. Int J Lang Commun Disord 2000;35:165-188. (Pubitemid 30209428)
2. Shriberg LD. Diagnostic markers for child speech-sound disorders: introductory comments. Clin Linguist Phon 2003;17:501-505. (Pubitemid 37361306)
3. Bishop DV. What causes specific language impairment in children? Curr Dir Psychol Sci 2006;15:217-221. (Pubitemid 44800063)
4. Bishop DV, Adams C. A prospective study of the relationship between specific language impairment, phonological disorders and reading retardation. J Child Psychol Psychiatry 1990;31:1027-1050.
5. Clarke T, Strug LJ, Murphy PL, et al. High risk of reading disability and speech sound disorder in rolandic epilepsy families: case-control study. Epilepsia 2007;48:2258-2265. (Pubitemid 350243414)
6. American Speech-Language-Hearing Association. Childhood apraxia of speech;2007.
7. Overvliet GM, Besseling RM, Vles JS, et al. Nocturnal epileptiform EEG discharges, nocturnal epileptic seizures, and language impairments in children: review of the literature. Epilepsy Behav 2010;19:550-558.
8. Caplan R, Siddarth P, Vona P, et al. Language in pediatric epilepsy. Epilepsia 2009;50:2397-2407.
9. Jones JE, Siddarth P, Gurbani S, et al. Cognition, academic achievement, language, and psychopathology in pediatric chronic epilepsy: short-term outcomes. Epilepsy Behav 2010;18:211-217.
10. Dunn DW, Johnson CS, Perkins SM, et al. Academic problems in children with seizures: relationships with neuropsychological functioning and family vari ables during the 3 years after onset. Epilepsy Behav 2010;19:455-461.
11. Benn EK, Hesdorffer DC, Levy SR, et al. Parental report of behavioral and cognitive diagnoses in childhood-onset epilepsy: a case-sibling-controlled analysis. Epilepsy Behav 2010;18:276-279.
12. Caplan R, Levitt J, Siddarth P, et al. Language and brain volumes in children with epilepsy. Epilepsy Behav 2010;17:402-407.
13. Vlooswijk MC, Jansen JF, Majoie HJ, et al. Functional connectivity and language impairment in cryptogenic localization-related epilepsy. Neurology 2010;75:395-402.
14. Bali B, Kull L, Strug L, et al. Autosomal dominant inheritance of centrotem-poral sharp waves in rolandic epilepsy families. Epilepsia 2007;48:2266-2272. (Pubitemid 350243400)
15. Pal DK, Li W, Clarke T, et al. Pleiotropic effects of the 11p13 locus on developmental verbal dyspraxia and EEG centrotemporal sharp waves. Genes Brain Behav 2010;9:1004-1012.
16. Strug LJ, Clarke T, Chiang T, et al. Centrotemporal sharp wave EEG trait in rolandic epilepsy maps to Elongator Protein Complex 4 (ELP4). Eur J Hum Genet 2009;17:1171-1181.
17. ParkJI, KimSJ, Kim HG. Acoustic effects of carbamazepine in benign rolandic epilepsy. Epilepsy Behav 2005;7:468-471. (Pubitemid 41614142)
18. Yun M, Choi YM, Eun SH, et al. Acoustic effects of lamotrigine in pediatric patients with epilepsy. Brain Dev 2010. [Epub ahead of print]
19. Pressler RM, Binnie CD, Coleshill SG, et al. Effect of lamotrigine on cognition in children with epilepsy. Neurology 2006;66:1495-1499. (Pubitemid 43958542)
20. Binnie CD. Cognitive impairment during epileptiform discharges: is it ever justifiable to treat the EEG? Lancet Neurol 2003;2:725-730. (Pubitemid 37443514)
21. Billard C, Hassairi I, Delteil F. Specific language impairment and electroencephalogram: which recommendations in clinical practice? A cohort of 24 children. Arch Pediatr 2010;17:350-358.
22. Kumar RA, KaraMohamed S, Sudi J, et al. Recurrent 16p11.2 microdeletions in autism. Hum Mol Genet 2008;17:628-638. (Pubitemid 351201774)
23. Weiss LA, Shen Y, Korn JM, et al. Association between microdeletion and microduplication at 16p11.2 and autism. N Engl J Med 2008;358:667-675. (Pubitemid 351240746)
24. Shinawi M, Liu P, Kang SH, et al. Recurrent reciprocal 16p11.2 rearrange-ments associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. J Med Genet 2010;47:332-341.
25. Reutlinger C, Helbig I, Gawelczyk B, et al. Deletions in 16p13 including GRIN2A in patients with intellectual disability, various dysmorphic features, and seizure disorders of the rolandic region. Epilepsia 2010;51:1870-1873.
26. Brunetti-Pierri N, Paciorkowski AR, Ciccone R, et al. Duplications of FOXG1 in 14q12 are associated with developmental epilepsy, mental retardation, and severe speech impairment. Eur J Hum Genet 2011;19:102-107.
27. Jaillard S, Dubourg C, Gerard-Blanluet M, et al. 2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features? J Med Genet 2009;46:847-855.
28. Williams SR, Mullegama SV, Rosenfeld JA, et al. Haploinsufficiency of MBD5 associated with a syndrome involving microcephaly, intellectual disabilities, severe speech impairment, and seizures. Eur J Hum Genet 2010;18:436-441.
29. Van Bon BW, Koolen DA, Brueton L, et al. The 2q23.1 microdeletion syndrome: clinical and behavioural phenotype. Eur J Hum Genet 2010;18:163-170.
30. Zweier C, de Jong EK, Zweier M, et al. CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila. Am J Hum Genet 2009;85:655-666.
31. Alarcon M, Abrahams BS, Stone JL, et al. Linkage, association, and gene-expression analyses identify CNTNAP2 as an autism-susceptibility gene. Am J Hum Genet 2008;82:150-159. (Pubitemid 351726082)
32. Arking DE, Cutler DJ, Brune CW, et al. A common genetic variant in the neurexin superfamily member CNTNAP2 increases familial risk of autism. Am J Hum Genet 2008;82:160-164. (Pubitemid 351726090)
33. Strauss KA, Puffenberger EG, Huentelman MJ, et al. Recessive symptomatic focal epilepsy and mutant contactin-associated protein-like 2. N Engl J Med 2006;354:1370-1377.
34. Vernes SC, Newbury DF, Abrahams BS, et al. A functional genetic link between distinct developmental language disorders. N Engl J Med 2008;359:2337-2345.
35. Roll P, Vernes SC, Bruneau N, et al. Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex. Hum Mol Genet 2010;19:4848-4860.
36. Lai CS, Fisher SE, Hurst JA, et al. A forkhead-domain gene is mutated in a severe speech and language disorder. Nature 2001;413:519-523. (Pubitemid 32938749)
37. Roll P, Rudolf G, Pereira S, et al. SRPX2 mutations in disorders of language cortex and cognition. Hum Mol Genet 2006;15:1195-1207.
38. Abrahams BS, Tentler D, Perederiy JV, et al. Genome-wide analyses of human perisylvian cerebral cortical patterning. Proc Natl Acad Sci USA 2007;104:17849-17854. (Pubitemid 350210923)